DOCSLIB.ORG

Part I the Synthesis of Proline-Containing Polypeptides Part Ii Chemical Shift Nonequivalence in 2,4-Dinitrophenyl Sulfenamides

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Part I the Synthesis of Proline-Containing Polypeptides Part Ii Chemical Shift Nonequivalence in 2,4-Dinitrophenyl Sulfenamides University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 1975 PART I THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES PART II CHEMICAL SHIFT NONEQUIVALENCE IN 2,4-DINITROPHENYL SULFENAMIDES THOMAS DAVID HARRIS Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation HARRIS, THOMAS DAVID, "PART I THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES PART II CHEMICAL SHIFT NONEQUIVALENCE IN 2,4-DINITROPHENYL SULFENAMIDES" (1975). Doctoral Dissertations. 1082. https://scholars.unh.edu/dissertation/1082 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1. The sign or “target" for pages apparently lacking from the document photographed is “Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image. You will find a good image of the page in the adjacent frame. 3. When a map, drawing or chart, etc., was part of the material being photographed the photographer followed a definite method in “ sectioning" the material. It is customary to begin photoing at the upper left hand corner of a large sheet and to continue photoing from left to right in equal sections with a small overlap. If necessary, sectioning is continued again — beginning below the first row and continuing on until complete. 4. The majority of users indicate that the textual content is of greatest value, however, a somewhat higher quality reproduction could be made from "photographs" if essential to the understanding of the dissertation. Silver prints of "photographs" may be ordered at additional charge by writing the Order Department, giving the catalog number, title, author and specific pages you wish reproduced. 5. PLEASE NOTE: Some pages may have indistinct print. Filmed as received. Xerox University Microfilms 300 North Zeeb Road Ann Arbor, Michigan 48106 75-19,874 HARRIS, Thomas David, 1948- PART I. THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES. PART II. CHEMICAL SHIFT NONEQUIVALENCE IN 2,4 -DINITROPHENYLSULFENAMIDES. University of New Hampshire, Ph.D., 1975 Chemistry, organic Xerox University Microfilms, Ann Arbor, Michigan 48106 THIS DISSERTATION HAS BEEN MICROFILMED EXACTLY AS RECEIVED. PART I. THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES PART II. CHEMICAL SHIFT NONEQUIVALENCE IN 2,4-DINITROPHENYLSULFENAMIDES by THOMAS D. HARRIS B. S., Saginaw Valley College, 1971 A THESIS Submitted to the University of New Hampshire In Partial Fulfillment of The Requirements for the Degree of Doctor of Philosophy Graduate School Department of Chemistry May, 1975 This thesis has been examined and approved. /I Thesis director, Robert E. Lyle Professor of Chemistry Jame5s5 DD.. MMoorrrriissoonn Professor of Chemistry 3. John Uebel, Professor of Chemistry N. Dennis Chasteen, Associate Professor of Chemistry Gerald L. Klippenstein Associate Professor of Biochemistry Date thesis is dedicated to my wife, Susan, and to my parents. ACKNOWLEDGEMENTS The author would like to express his appreciation to Dr. Robert E. Lyle for providing and directing the research problem and for his guidance and enthusiasm during all stages of the research. He would also like to thank Dr. James D. Morrison and Dr. J. John Uebel for their helpful discussions during the course of the research and for their aid in the development of this thesis manuscript. To the other members of the Faculty and Staff of the Chemistry Department, the author wishes to express his apprec­ iation for the educational opportunity which they have pro­ vided. Special thanks are also given to Mrs. Deanna Cardin for performing the elemental analyses and to Miss Anne Kohl for her assistance in the preparation of this manuscript. Thanks are extended also to Rita Furman for the anti­ biotic assay and to the National Institutes of Health for providing the results of the antifertility screening. The author expresses his appreciation to the University of New Hampshire for providing him with financial support in the way of UNH Summer Fellowships. Finally, the author would like to thank his colleague Dr. Richard Davenport for his consultation and encouragement during the course of this research project. TABLE OF CONTENTS LIST OF TABLES............................................... xiii LIST OF FIGURES............................................... xiv ABSTRACT........................................................ xv PART I. THE SYNTHESIS OF PROLINE-CONTAINING POLYPEPTIDES1 SECTION I. INTRODUCTION....................................... 2 SECTION II. RESUSTS AND DISCUSSION......................... 10 General Considerations of Peptide Synthesis............ 10 Preparation of N-Hexanoylglycyl-L-prolyl-5- aminovaleric Acid (19j............................. 17 An Alternate Approach to N-Hexanoylglycyl-L- prolyl-5-arainovaleric Acid (lj))................... 23 Preparation of N-Pentanoylglycyl-L-prolyl-5- aminovaleric Acid Methyl Ester (3C0.............. 2 8 Preparation of N-Hexanoylglycyl-L-prolylglycyl- glycine (^6).........................................31 Synthesis of a FSH/LH-RF Analog ........................ 34 Preparation of N-Hexanoylglycly-L-prolyl-L-leucyl- L-leucine (56j...................................... 35 Preparation of N-Pentanoylglycyl-L-prolyl-L- luecyl-L-leucine (159).............................. 46 Preparation of N-Pentanoylglycyl-D-prolyl-L- phenylalanyl-L-leucine {19).........................48 Attempted Preparation of Derivatives of 5- Hydroxyproline...................................... 54 Biological Results ....................................... 60 v SECTION III. EXPERIMENTAL.................................... 64 General.................................................... 64 Melting Points...................................... 64 Boiling Points...................................... 64 Elemental Analyses.................................. 64 Infrared Spectra.................................... 64 Nuclear Magnetic Resonance Spectra................. 64 Materials and Methods.............................. 65 Reagents....................................... 65 Solvents........................................66 Products........................................66 Experimental Methods.......................... 66 Thin Layer Chromatography.................... 67 Preparation of Hexanoyl Chloride (10^).................. 6 8 Preparation of N-Hexanoylglycine Ethyl Ester (15) .... 68 Preparation of N-Hexanoylglycine (!L2).................. 68 Method A ............................................. 68 Method B ............................................. 69 Method C ............................................. 69 Preparation of N-Hexanoylglycyl-L-prolyl-5-amino- valeric Acid (19J . Method A ..................... 70 Attempted Preparation of N-Hexanoylglycyl-L-prolyl- 5-aminovaleric Acid (19J........................... 72 Preparation of N-Benzyloxycarbonyl-L-proline (2_2) ... .73 Preparation of Methyl 5-Aminovalerate Hydrochloride (21).................................................. 74 Preparation of L-Prolyl-5-aminovaleric Acid Methyl Ester (25)................................... 74 Preparation of N-Hexanoylglycyl-L-prolyl-5-amino- valeric Acid Methyl Ester (21).................... 76 Preparation of N-Hexanoylglycyl-L-prolyl-5-amino- Acid (19^). Method B ............................... 77 Preparation of Pentanoyl Chloride (28)................ 77 Preparation of N-Pentanoylglycine (29)................ 77 Method A ............................................. 77 Method B ............................................. 78 vi Preparation of N-Pentanoylglycyl-L-prolyl-5-amino- valeric Acid Methyl Ester (30^).................. 78 Method A .............................................78 Method B .......................................79 Preparation of L-Proline Methyl Ester (_31).............80 Preparation of N-Hexanoylglycyl-L-proline Methyl Ester (32^........................................... 80 Preparation of N-Hexanoylglycyl-L-proline (33)....... 81 Method A ............................................. 81 Method B ............................................. 82 Preparation of N-Hexanoylglycyl-L-prolylglycyl- glycine Benzyl Ester (350......................... 82 Method A ............................................. 82 Method B ............................................. 83 Preparation of N-Hexanoylglycyl-L-prolylglycyl- glycine (36)........................................ 83 Preparation of N-Hexanoylglycyl-L-prolylglycyl- glycinamide
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh Et Al
    US 2005OO65361A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh et al. (43) Pub. Date: Mar. 24, 2005 (54) PROCESS FOR PREPARING ALKYLARYL (22) Filed: Sep. 22, 2003 CHLOROFORMATES Publication Classification (76) Inventors: Abdul Rakeeb Abdul Subhan Deshmukh, Maharashtra (IN); Vikas (51) Int. Cl." ........................... C07C 69/74; C07C 69/96 Kalyanrao Gumaste, Maharashtra (IN) (52) U.S. Cl. .............................................................. 558/280 Correspondence Address: (57) ABSTRACT NIXON & VANDERHYE, PC The present invention discloses an improved method for the 1100 N GLEBE ROAD preparation of alky/aryl chloroformates directly from alco 8TH FLOOR hols and triphosgene. This method is simple, mild and ARLINGTON, VA 22201-4714 (US) efficient avoids use of hazardous phosgene. It can be used for the preparation of various aryl as well as alkyl chlorofor (21) Appl. No.: 10/665,410 mates in excellent yields. US 2005/0065361 A1 Mar. 24, 2005 PROCESS FOR PREPARING ALKYLARYL Maligres, K. C. Nicolau, W. Wrasidio Bioorg. Med. Chem. CHLOROFORMATES Lett. 1993, 3, 1051. (c) D. C. Horwell, J. Hughes, J. Hunter, M. C. Pritchard, R. S. Richardson, E. Roberts, G. N. FIELD OF THE INVENTION Woodruff J. Med. Chem., 1991, 34, 404 and tertiary amines as base H. Eckert, B. Forster, Angew. Chem. Int. Ed. Engl., 0001. The present invention relates to a process for 1987,26,894). Hydroquinone is also used in the preparation preparing alkyl/aryl chloroformates. More particularly, the of chloroformates from triphosgene G. Van den Mooter, C. present invention relates to a process for preparing com Samyn, R. Kinget Int. J. Pharm., 1993, 97, 133).
    [Show full text]
  • Al Exposure Increases Proline Levels by Different Pathways in An
    www.nature.com/scientificreports OPEN Al exposure increases proline levels by diferent pathways in an Al‑sensitive and an Al‑tolerant rye genotype Alexandra de Sousa1,2, Hamada AbdElgawad2,4, Fernanda Fidalgo1, Jorge Teixeira1, Manuela Matos3, Badreldin A. Hamed4, Samy Selim5, Wael N. Hozzein6, Gerrit T. S. Beemster2 & Han Asard2* Aluminium (Al) toxicity limits crop productivity, particularly at low soil pH. Proline (Pro) plays a role in protecting plants against various abiotic stresses. Using the relatively Al‑tolerant cereal rye (Secale cereale L.), we evaluated Pro metabolism in roots and shoots of two genotypes difering in Al tolerance, var. RioDeva (sensitive) and var. Beira (tolerant). Most enzyme activities and metabolites of Pro biosynthesis were analysed. Al induced increases in Pro levels in each genotype, but the mechanisms were diferent and were also diferent between roots and shoots. The Al‑tolerant genotype accumulated highest Pro levels and this stronger increase was ascribed to simultaneous activation of the ornithine (Orn)‑biosynthetic pathway and decrease in Pro oxidation. The Orn pathway was particularly enhanced in roots. Nitrate reductase (NR) activity, N levels, and N/C ratios demonstrate that N‑metabolism is less inhibited in the Al‑tolerant line. The correlation between Pro changes and diferences in Al‑sensitivity between these two genotypes, supports a role for Pro in Al tolerance. Our results suggest that diferential responses in Pro biosynthesis may be linked to N‑availability. Understanding the role of Pro in diferences between genotypes in stress responses, could be valuable in plant selection and breeding for Al resistance. Proline (Pro) is involved in a wide range of plant physiological and developmental processes1.
    [Show full text]
  • Chapter 6 Industrial Applications of Multicomponent Reactions (Mcrs)
    University of Groningen Innovative multicomponent reactions and their use in medicinal chemistry Zarganes Tzitzikas, Tryfon IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2017 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Zarganes Tzitzikas, T. (2017). Innovative multicomponent reactions and their use in medicinal chemistry. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 24-09-2021 CHAPTER 6 INDUSTRIAL APPLICATIONS OF MULTICOMPONENT REACTIONS (MCRS) Chapter contained in the Rodriguez-Bonne book Stereoselectve Multple Bond-Forming Transformatons in Organic Synthesis 2015 by John Wiley & Sons, Inc. Tryfon Zarganes – Tzitzikas, Ahmad Yazbak, Alexander Dömling Chapter 6 INTRODUCTION Multcomponent reactons (MCRs) can be defned as processes in which three or more reactants introduced simultaneously are combined through covalent bonds to form a single product, regardless of the mechanisms and protocols involved.[1] Many basic MCRs are name reactons, for example, Ugi,[2] Passerini,[3] van Leusen,[4] Strecker,[5] Hantzsch,[6] Biginelli,[7] or one of their many variatons.
    [Show full text]
  • Amino Acid Catalyzed Direct Asymmetric Aldol Reactions: a Bioorganic Approach to Catalytic Asymmetric Carbon-Carbon Bond-Forming Reactions
    5260 J. Am. Chem. Soc. 2001, 123, 5260-5267 Amino Acid Catalyzed Direct Asymmetric Aldol Reactions: A Bioorganic Approach to Catalytic Asymmetric Carbon-Carbon Bond-Forming Reactions Kandasamy Sakthivel, Wolfgang Notz, Tommy Bui, and Carlos F. Barbas III* Contribution from The Skaggs Institute for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 ReceiVed January 3, 2001 Abstract: Direct asymmetric catalytic aldol reactions have been successfully performed using aldehydes and unmodified ketones together with commercially available chiral cyclic secondary amines as catalysts. Structure- based catalyst screening identified L-proline and 5,5-dimethyl thiazolidinium-4-carboxylate (DMTC) as the most powerful amino acid catalysts for the reaction of both acyclic and cyclic ketones as aldol donors with aromatic and aliphatic aldehydes to afford the corresponding aldol products with high regio-, diastereo-, and enantioselectivities. Reactions employing hydroxyacetone as an aldol donor provide anti-1,2-diols as the major product with ee values up to >99%. The reactions are assumed to proceed via a metal-free Zimmerman- Traxler-type transition state and involve an enamine intermediate. The observed stereochemistry of the products is in accordance with the proposed transition state. Further supporting evidence is provided by the lack of nonlinear effects. The reactions tolerate a small amount of water (<4 vol %), do not require inert reaction conditions and preformed enolate equivalents, and can be conveniently performed at room temperature in various solvents. In addition, reaction conditions that facilitate catalyst recovery as well as immobilization are described. Finally, mechanistically related addition reactions such as ketone additions to imines (Mannich- type reactions) and to nitro-olefins and R,â-unsaturated diesters (Michael-type reactions) have also been developed.
    [Show full text]
  • Proline- and Alanine-Rich N-Terminal Extension of the Basic Bovine P-Crystallin B1 Chains
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Volume 161, number 2 FEBS 0790 September 1983 Proline- and alanine-rich N-terminal extension of the basic bovine P-crystallin B1 chains G.A.M. Berbers, W.A. Hoekman, H. Bloemendal, W.W. de Jong, T. Kleinschmidt* and G. Braunitzer* Laboratorium voor Biochemie, Universiteit van Nijmegen, Geert Grooteplein Noord 21, 6525 EZ Nijmegen, The Netherlands and *Max-Planck-Institut ft’ir Biochemie, Abteilung Proteinchemie, D-8033 Martinsried bei Miinchen, FRG Received 22 June 1983 The amino acid sequence of the N-terminal region of the two basic bovine &crystallin B1 chains has been analyzed. The results reveal that @Bibis derived in vivo from the primary gene product @la by removal of a short N-terminal sequence. It appears that them1 chains have the same domain structure as observed in other /3- and y-crystallin chains. They have, however, a very long N-terminal extension in comparison with other &chains. This extension is mainly composed of a remarkable Pro- and Ala-rich sequence, which suggests an interaction of these structural proteins with the cytoskeleton and/or the plasma membranes of the lens cells. Protein sequence Bovine &crystallin N-terminal extension Proline- and aianine-rich Domain structure 1. INTRODUCTION 33 000 and 31000, respectively, are characteristic for fltikt, [ 111. ,8Fha is a primary gene product, from The crystallins are evolutionary highly conserv- which ,8&b arises by post-translational modifica- ed structural eye lens proteins, which can be divid; tion [lo-121, most probably a proteolytic step ed into 4 classes: (Y-,,&, y- and t-crystallin [ 11.
    [Show full text]
  • The Preparation of Certain Organic Chloroformates and Carbonates
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 1947-04-01 The preparation of certain organic chloroformates and carbonates Robert E. Brailsford Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd BYU ScholarsArchive Citation Brailsford, Robert E., "The preparation of certain organic chloroformates and carbonates" (1947). Theses and Dissertations. 8175. https://scholarsarchive.byu.edu/etd/8175 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. THE PREPARATI OH OF CERTAI N 0RG.1NIC CHLOROFORJ.'\Ll.TES AND CARBON T Thesis ubmitted to the Department of Chemistry Brigham Young University ~ .. ... "') .~ . ~ . "'). ... .. .. .. .. , ... .. ... : : ....: . ..-. ~ ..·.: : ..: ...• : ·.. ~ . : ,.. .~ : :. : ·: : ··.... ; ~ : ·. : : .: . : . : : : ••• .... •." •,.r_·: -••• ~ .... In Parti a l Fulfillment of the Re~uirements for the Degree Master of cienoe 147143 by Robert E. Brailsford .tipril 1947 This Thesis by Robert E. Brailsford is accepted in its present farm by the Department of Chemistry of Brigham Young University as satisfying the ·rhesis requirement for the degree of Master of Science. PREFACE flhile working for the Hooker Electrochemical Company of Niagara Falls , New York , from April 3 , 1943 , to January 30 , 1946 , the writer became interested in organic chloroformates and. carbonates , an interest instigated by requests from B. F . Goodrich Company for a number of samples . fter returning to Brigham Young University that preliminary interest was revived and the experi - mental work of this thesis was performed. under the direction of Dr . Charles ' . :Maw and Professor Joseph K.
    [Show full text]
  • Carbonate and Benzyl Benzotriazol-L-Yl Carbonate. Now
    70 Bull. Korean Chem. Soc., Vol. 7, No. 1, 1986 Sunggak Kim and Heung Chang t-Butyl Benzotriazol-l-yl Carbonate and Benzyl Benzotriazol-l-yl Carbonate. Now Reactive Amino Protective Reagents for t-Butoxy carbonylation and Benzyloxycarbonylation of Amines and Amino Acids Sunggak Kim* and Heung Chang Department of Chemistry, Korea Advanced Institute of Science and Technology, Seoul 131, Received September24,1985 New amino protective reagents, /-butyl benzotriazol-l-yl carbonate and benzyl benzotriazol-l-yl carbonate, for t~ butoxycarbonylation and benzyloxycarbonylation of amines and amino acids have been developed. f-Butyl benzotriazol-1 -yl carbonate reacts rapidly and cleanly with various amines and amino acids to afford N-Boc amines and N-Boc amino acids in high yields and benzyl benzotriazol-l-yl carbonate is also found to be very effective in the benzyloxycarbonylation of amino acids. Introduction a solution of an equimolar amount of 1-hydroxybenzotriazole and pyridine in methylene chloride to the solution of an ex­ The Z-butoxycarbonyl (Boc) group is one of the most im­ cess amount of phosgene in toluene under cooling portant amino protective groups along with benzyloxycarbonyl (-20~ 一 10°C). The resulting product was relatively unstable (Cbz) group in peptide synthesis.1 Since /-butyl chloroformate and was mainly decomposed to 1-hydroxybenzotriazole dur­ is only fairly stable above 10°C,2 it is difficult to is이 ate t- ing workup with cold water. Thus； benzotriazol-l-yl chlorofor­ butyl chloroformate as a pure form in high yields. Thus, con­ mate was used in a crude form. BBC could be prepared readily siderable efforts have been devoted to the development of a by the reaction of benzotriazol-l-yl chloroformate with variety of useful and reliable reagents for the preparation of equimolar amounts of f나 mtyl alcohol and pyridine in N-Boc amino acids during last 30 years.1 methylene chloride at room temperature for 2 h (eq.
    [Show full text]
  • Benzyl Chloroformate (CHLOROFORMIC ACID, BENZYL ESTER)
    Rev B Benzyl Chloroformate (CHLOROFORMIC ACID, BENZYL ESTER) C8H7O2Cl Molecular Weight = 170.6 CAS# 501‐53‐1 SPECIFICATIONS Assay: 98.% min. Color (APHA): 50 max. Benzyl Alcohol: 0.1% max. Hydrogen Chloride: 0.1% max. Benzyl Chloride: 1.5% max. Phosgene: 0.1% max. Dibenzyl Carbonate: 0.5% max. Iron: 1.5 PPM max. PHYSICAL PROPERTIES Appearance: Clear liquid free of visible contaminants BP: Decomposes at elevated temperature Odor: Pungent Density: 1.195 ‐1.22 MP/Range: ‐30°C Flash Point: 126°C NOTICE: The technical information and suggestions for use made herein are based on VanDeMark’s research and experience and are believed to be reliable, but such information and suggestions do not constitute a warranty, and no patent liability can be assumed. This publication is not to be taken as a license to operate under or infringe on any patents. Since VanDeMark has no control over the conditions under which the product is transported, stored, handled, used or applied, buyer must determine for himself by preliminary tests or otherwise, the suitability of the product for his purposes. VanDeMark’s liability on any basis is limited to the price of the product used. The information in this bulletin supersedes all previously issued bulletins on the subject matter covered. VanDeMark Benzyl Chloroformate APPLICATIONS SPILLS AND DISPOSAL Benzyl Chloroformate is a reactive chemical intermediate Use personal protective equipment (see MSDS). used in the synthesis of pharmaceutical and agrochemical Evacuate personnel to safe areas. Dike far ahead of products. It is used as a reagent in peptide synthesis to liquid spill for later disposal.
    [Show full text]
  • Jp Xvii the Japanese Pharmacopoeia
    JP XVII THE JAPANESE PHARMACOPOEIA SEVENTEENTH EDITION Official from April 1, 2016 English Version THE MINISTRY OF HEALTH, LABOUR AND WELFARE Notice: This English Version of the Japanese Pharmacopoeia is published for the convenience of users unfamiliar with the Japanese language. When and if any discrepancy arises between the Japanese original and its English translation, the former is authentic. The Ministry of Health, Labour and Welfare Ministerial Notification No. 64 Pursuant to Paragraph 1, Article 41 of the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices (Law No. 145, 1960), the Japanese Pharmacopoeia (Ministerial Notification No. 65, 2011), which has been established as follows*, shall be applied on April 1, 2016. However, in the case of drugs which are listed in the Pharmacopoeia (hereinafter referred to as ``previ- ous Pharmacopoeia'') [limited to those listed in the Japanese Pharmacopoeia whose standards are changed in accordance with this notification (hereinafter referred to as ``new Pharmacopoeia'')] and have been approved as of April 1, 2016 as prescribed under Paragraph 1, Article 14 of the same law [including drugs the Minister of Health, Labour and Welfare specifies (the Ministry of Health and Welfare Ministerial Notification No. 104, 1994) as of March 31, 2016 as those exempted from marketing approval pursuant to Paragraph 1, Article 14 of the Same Law (hereinafter referred to as ``drugs exempted from approval'')], the Name and Standards established in the previous Pharmacopoeia (limited to part of the Name and Standards for the drugs concerned) may be accepted to conform to the Name and Standards established in the new Pharmacopoeia before and on September 30, 2017.
    [Show full text]
  • Synthesis, Utility and Medicinal Importance of 1,2- & 1,4
    RSC Advances REVIEW View Article Online View Journal | View Issue Synthesis, utility and medicinal importance of 1,2- & 1,4-dihydropyridines Cite this: RSC Adv.,2017,7, 2682 Vivek K. Sharmaa and Sunil K. Singh*b Dihydropyridine (DHP) is among the most beneficial scaffolds that have revolutionised pharmaceutical research with unprecedented biological properties. Over the years, metamorphosis of easily accessible 1,2- and 1,4-dihydropyridine (1,4-DHP) intermediates by synthetic chemists has generated several drug molecules and natural products such as alkaloids. The 1,4-dihydropyridine (1,4-DHP) moiety itself is the main fulcrum of several approved drugs. The present review aims to collate the literature of 1,2- and the 1,4-DHPs relevant to synthetic and medicinal chemists. We will describe various Received 6th October 2016 methodologies that have been used for the synthesis of this class of compounds, including the Accepted 14th November 2016 strategies which can furnish enantiopure DHPs, either by asymmetric synthesis or by chiral resolution. DOI: 10.1039/c6ra24823c We will also elaborate the significance of DHPs towards the synthesis of natural products of medicinal www.rsc.org/advances merit. Creative Commons Attribution 3.0 Unported Licence. 1. Introduction oxidation–reduction reactions, has made the 1,4-DHP core even more lucrative. Perhaps less studied in the past, the potential of Arthur Hantzsch added one of the most valuable scaffolds to the 1,2-dihydropyridines has recently been explored as a critical toolbox of medicinal chemists, reporting the synthesis of scaffold for the synthesis of alkaloids and other drugs. 1,2-DHPs dihydropyridine (DHP) in 1882.
    [Show full text]
  • Arginine Is Synthesized from Proline, Not Glutamate, in Enterally Fed Human Preterm Neonates
    0031-3998/11/6901-0046 Vol. 69, No. 1, 2011 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2010 International Pediatric Research Foundation, Inc. Arginine Is Synthesized From Proline, Not Glutamate, in Enterally Fed Human Preterm Neonates CHRIS TOMLINSON, MAHROUKH RAFII, MICHAEL SGRO, RONALD O. BALL, AND PAUL PENCHARZ Department of Paediatrics [C.T., M.S., P.P.], Research Institute [C.T., M.R., P.P.], The Hospital for Sick Children, Toronto, Ontario M5G1X8, Canada; Department of Nutritional Sciences [C.T., M.S., P.P.], University of Toronto, Toronto, Ontario M5S3E2, Canada; Department of Paediatrics [M.S.], St Michael’s Hospital, Toronto, Ontario M5B1W8, Canada; Department of Agricultural, Food and Nutritional Science [R.O.B., P.P.], University of Alberta, Edmonton, Alberta T6G2P5, Canada ABSTRACT: In neonatal mammals, arginine is synthesized in the litis (NEC) (8) and pulmonary hypertension (9). Furthermore, enterocyte, with either proline or glutamate as the dietary precursor. arginine supplementation was shown to reduce the incidence We have shown several times in piglets that proline is the only of all stages of NEC in moderately at risk infants (10) and a precursor to arginine, although in vitro evidence supports glutamate single bolus infusion of i.v. arginine improved oxygenation in in this role. Because of this uncertainty, we performed a multitracer infants with pulmonary hypertension (11). Therefore, because stable isotope study to determine whether proline, glutamate, or both are dietary precursors for arginine in enterally fed human neonates. arginine is clearly important for metabolism in the neonate, it Labeled arginine (M ϩ 2), proline (M ϩ 1), and glutamate (M ϩ 3) is critical to understand the metabolic pathways involved in its were given enterally to 15 stable, growing preterm infants (GA at synthesis.
    [Show full text]
  • Electrochemical Analysis of Evans Blue by Surfactant Modified Carbon Nanotube Paste Electrode B
    Journal of Materials and J. Mater. Environ. Sci., 2019, Volume 10, Issue 9, Page 882-890 Environmental Sciences ISSN : 2028-2508 CODEN : JMESCN http://www.jmaterenvironsci.com Copyright © 2019, University of Mohammed Premier Oujda Morocco Electrochemical Analysis of Evans Blue by Surfactant Modified Carbon Nanotube Paste Electrode 1,2 1* 2 1 B. M. Amrutha , J. G. Manjunatha , S. Aarti Bhatt , N. Hareesha 1 Department of Chemistry, FMKMC College, Madikeri, Constituent College of Mangalore University, Karnataka, India 2 Department of Chemistry, NMAM Institute of Technology, Nitte, Karnataka, India. Received 08 Jul 2019, Abstract Revised 08 Aug 2019, Electrochemical sensor for the specific and sensitive detection of Evans blue (EB) at Accepted 10 Aug 2019 physiological pH in 0.2M phosphate buffer solution (PBS) was developed by the surface modification using Triton X -100 (TX-100) surfactant. The cyclic voltammetry (CV) studies show enhanced peak separation, appreciable sensitivity, selectivity and stability Keywords which allowed this TX-100 surfactant modified carbon nanotube paste electrode (TX- Cyclic Voltammetry, 100MCNTPE) to analyse EB individually and simultaneously along with tartrazine (TZ) in Carbon nanotube, the potential range of 0.2 V to 0.7 V. The electrode morphology was characterised by field TX-100, emission scanning electron microscopy (FESEM). The oxidation potential of EB shifted Evans blue, negatively, and enhanced irreversible oxidation peak current was observed at 0.505V which Tartrazine. served as the analytical response. In the prime condition, the anodic peak current of EB increased linearly, and two linear ranges were observed from 10 µM to 100 µM with the [email protected] limit of detection (LOD) of 5.06 µM and limit of quantification (LOQ) of 16.87 µM.
    [Show full text]